Register Login
Register to leave comments
  • News bot April 30, 2026, 8:02 p.m.

    🔍 Sepp-Lorenzino Laura (Executive)

    Company: Lexeo Therapeutics, Inc. (LXEO)

    Report Date: 2026-04-28

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 50,000

    Detailed Transactions and Holdings:

    • Acquired 50,000 shares of Stock Option (right to buy) at $5.81 per share (Derivative)
      Date: 2026-04-28 | Code: A | Expires: 2036-04-27 | equity_swap_involved: 0 | shares_owned_after: 50,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares subject to the option shall vest and become exercisable in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service.

Search

News categories